바이오센서 시장 규모, 점유율, 성장 및 세계 산업 분석 : 종류별, 용도별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of biosensors Market

The global biosensors market is witnessing strong growth due to rising demand for rapid, accurate, and minimally invasive diagnostic solutions across healthcare and non-healthcare applications. According to Fortune Business Insights, the biosensors market size was valued at USD 29.88 billion in 2025 and is projected to grow to USD 32.60 billion in 2026. With expanding adoption across clinical diagnostics, health monitoring, and point-of-care testing, the market is forecasted to reach USD 67.10 billion by 2034, exhibiting a CAGR of 9.44% during the 2026-2034 forecast period.

North America dominated the global biosensors market with a 44.53% share in 2025, supported by advanced healthcare infrastructure, high prevalence of chronic diseases, and strong adoption of wearable and point-of-care diagnostic technologies.

Market Overview

Biosensors are analytical devices that convert biological responses from enzymes, cells, or tissues into measurable electrical signals. These devices are widely used across medical diagnostics, agriculture, environmental monitoring, food safety, and biomedical research. In healthcare, biosensors enable early disease detection, continuous monitoring, and pain-free diagnostics, making them essential tools in modern clinical practice.

The increasing global burden of diabetes, cardiovascular diseases, and infectious disorders has significantly boosted demand for biosensor-based medical devices. Additionally, collaborations between semiconductor manufacturers and medical device companies are accelerating the development of highly precise biosensor platforms, further driving market growth.

Impact of COVID-19

The COVID-19 pandemic positively influenced the biosensors market in 2020 by accelerating the shift from centralized laboratory diagnostics to point-of-care and home-based testing. Increased adoption of self-testing and wearable biosensor-enabled devices continued during the post-pandemic period, supporting market growth in 2021 and beyond. Biosensors played a critical role in rapid diagnosis, disease surveillance, and remote patient monitoring.

Biosensors Market Trends

Rising Adoption of Biosensors for Diabetes Monitoring

One of the most prominent trends in the biosensors market is the growing deployment of devices for diabetes monitoring. Continuous glucose monitoring (CGM) systems using electrochemical biosensors are increasingly adopted across hospitals and homecare settings. These devices offer real-time monitoring, improved insulin management, and enhanced patient convenience.

According to Abbott, more than 3.0 million people worldwide were using the FreeStyle Libre CGM system in 2021, reflecting strong demand for biosensor-enabled diabetes solutions. Ongoing R&D efforts aimed at integrating insulin-monitoring biosensors with glucose sensors are expected to further strengthen adoption.

Market Growth Factors

Technological Advancements in Biosensors

Rapid advancements in nanomaterials, graphene-based sensors, fluorescence tagging, and fiber-optic technologies are significantly improving biosensor sensitivity, selectivity, and accuracy. These innovations are expanding biosensor applications across drug discovery, cancer diagnostics, and infectious disease testing.

For example, in January 2022, IDENTIFYSENSORS developed a graphene-based SARS-CoV-2 biosensor with approximately 96.0% sensitivity, highlighting the role of advanced materials in next-generation diagnostics.

Restraining Factors

Despite strong growth potential, the market faces challenges such as high production costs, limited sensor stability, and short device lifespan. Issues related to sensor degradation, drift, and frequent component replacement can restrict long-term adoption, particularly in resource-limited settings.

Segmentation Analysis

By Type

The market is segmented into electrochemical biosensors, optical biosensors, piezoelectric biosensors, and others.

Electrochemical biosensors dominated the market with an 80.60% share in 2026, driven by widespread adoption of glucose monitoring devices. Optical biosensors are expected to grow at the fastest rate due to increasing demand for non-invasive diagnostics.

By Application

Based on application, the market includes clinical diagnostics, health monitoring, and others.

The clinical diagnostics segment held the largest share of 67.22% in 2026, supported by the rising number of point-of-care diagnostic tests worldwide.

By End User

By end user, the market is segmented into medical device companies, CDMOs, and others.

Medical device companies dominated the market with a 73.14% share in 2026, owing to strong product development initiatives and growing demand for biosensor-enabled healthcare devices.

Regional Insights

The North America biosensors market was valued at USD 13.30 billion in 2025 and increased to USD 14.47 billion in 2026, driven by continuous product launches and regulatory approvals.

Europe held a significant share due to strong healthcare research funding and biosensor R&D initiatives.

Asia Pacific is expected to record the highest growth rate, supported by rising diabetes prevalence and increasing adoption of point-of-care diagnostics.

Competitive Landscape

The biosensors market is dominated by key players such as Abbott, Medtronic, F. Hoffmann-La Roche Ltd., DuPont, Universal Biosensors, and Koninklijke Philips N.V. These companies focus on strategic collaborations, product launches, and technological innovation to strengthen their global presence.

Conclusion

In conclusion, the global biosensors market, valued at USD 29.88 billion in 2025, is projected to grow to USD 32.60 billion in 2026 and further reach USD 67.10 billion by 2034. Growth is driven by rising chronic disease prevalence, technological advancements, and expanding adoption of point-of-care and home-based diagnostic solutions.

Growth Rate CAGR of 9.44% from 2026-2034

Segmentation By Type

• Electrochemical Biosensors
• Optical Sensors
• Piezoelectric Sensors
• Others

By Application

• Clinical Diagnostics
  • Glucose Monitoring
  • Infectious Disease Screening
  • Pregnancy & Fertility Testing
  • Others
• Health Monitoring
  • Vital Signs Monitoring
  • Activity Tracking
• Others

By End User

• Medical Device Companies
• Contract Development and Manufacturing Organizations (CDMOs)
• Others

By Region

• North America (By Type, By Application, By End User and By Country)
  • U.S.
  • Canada
• Europe (By Type, By Application, By End User and By Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (By Type, By Application, By End User and By Country/Sub-region)
  • Japan
  • China
  • India
  • Southeast Asia
  • Australia
  • Rest of Asia Pacific
• Latin America (By Type, By Application, By End User and By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, By Application, By End User and By Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview of R&D Expenditure, Key Players, 2025
• 4.2. Overview: Technological Advancements in Biosensors
• 4.3. Key Industry Developments - Partnerships, Mergers & Acquisitions
• 4.4. New Product Launches
• 4.5. Impact of COVID-19 on the Market

5. Global Biosensors Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Electrochemical Biosensors
  • 5.1.2. Optical Biosensors
  • 5.1.3. Piezoelectric Biosensors
  • 5.1.4. Others
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Clinical Diagnostics
    • 5.2.1.1. Glucose Monitoring
    • 5.2.1.2. Infectious Disease Screening
    • 5.2.1.3. Pregnancy & Fertility Testing
    • 5.2.1.4. Others
  • 5.2.2. Health Monitoring
    • 5.2.2.1. Vital Signs Monitoring
    • 5.2.2.2. Activity Tracking
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Medical Device Companies
  • 5.3.2. Contract Development and Manufacturing Organizations (CDMOs)
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Biosensors Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Electrochemical Biosensors
  • 6.1.2. Optical Biosensors
  • 6.1.3. Piezoelectric Biosensors
  • 6.1.4. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Clinical Diagnostics
    • 6.2.1.1. Glucose Monitoring
    • 6.2.1.2. Infectious Disease Screening
    • 6.2.1.3. Pregnancy & Fertility Testing
    • 6.2.1.4. Others
  • 6.2.2. Health Monitoring
    • 6.2.2.1. Vital Signs Monitoring
    • 6.2.2.2. Activity Tracking
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By End User
  • 6.3.1. Medical Device Companies
  • 6.3.2. Contract Development and Manufacturing Organizations (CDMOs)
  • 6.3.3. Others
• 6.4. Market Analysis - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Biosensors Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Electrochemical Biosensors
  • 7.1.2. Optical Biosensors
  • 7.1.3. Piezoelectric Biosensors
  • 7.1.4. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Clinical Diagnostics
    • 7.2.1.1. Glucose Monitoring
    • 7.2.1.2. Infectious Disease Screening
    • 7.2.1.3. Pregnancy & Fertility Testing
    • 7.2.1.4. Others
  • 7.2.2. Health Monitoring
    • 7.2.2.1. Vital Signs Monitoring
    • 7.2.2.2. Activity Tracking
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By End User
  • 7.3.1. Medical Device Companies
  • 7.3.2. Contract Development and Manufacturing Organizations (CDMOs)
  • 7.3.3. Others
• 7.4. Market Analysis - By Country/Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Rest of Europe

8. Asia pacific Biosensors Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Electrochemical Biosensors
  • 8.1.2. Optical Biosensors
  • 8.1.3. Piezoelectric Biosensors
  • 8.1.4. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Clinical Diagnostics
    • 8.2.1.1. Glucose Monitoring
    • 8.2.1.2. Infectious Disease Screening
    • 8.2.1.3. Pregnancy & Fertility Testing
    • 8.2.1.4. Others
  • 8.2.2. Health Monitoring
    • 8.2.2.1. Vital Signs Monitoring
    • 8.2.2.2. Activity Tracking
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By End User
  • 8.3.1. Medical Device Companies
  • 8.3.2. Contract Development and Manufacturing Organizations (CDMOs)
  • 8.3.3. Others
• 8.4. Market Analysis - By Country/Sub-region
  • 8.4.1. Japan
  • 8.4.2. Australia
  • 8.4.3. China
  • 8.4.4. India
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Biosensors Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Electrochemical Biosensors
  • 9.1.2. Optical Biosensors
  • 9.1.3. Piezoelectric Biosensors
  • 9.1.4. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Clinical Diagnostics
    • 9.2.1.1. Glucose Monitoring
    • 9.2.1.2. Infectious Disease Screening
    • 9.2.1.3. Pregnancy & Fertility Testing
    • 9.2.1.4. Others
  • 9.2.2. Health Monitoring
    • 9.2.2.1. Vital Signs Monitoring
    • 9.2.2.2. Activity Tracking
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By End User
  • 9.3.1. Medical Device Companies
  • 9.3.2. Contract Development and Manufacturing Organizations (CDMOs)
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Biosensors Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Electrochemical Biosensors
  • 10.1.2. Optical Biosensors
  • 10.1.3. Piezoelectric Biosensors
  • 10.1.4. Others
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Clinical Diagnostics
    • 10.2.1.1. Glucose Monitoring
    • 10.2.1.2. Infectious Disease Screening
    • 10.2.1.3. Pregnancy & Fertility Testing
    • 10.2.1.4. Others
  • 10.2.2. Health Monitoring
    • 10.2.2.1. Vital Signs Monitoring
    • 10.2.2.2. Activity Tracking
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By End User
  • 10.3.1. Medical Device Companies
  • 10.3.2. Contract Development and Manufacturing Organizations (CDMOs)
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Abbott
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Medtronic
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. F. Hoffmann-La Roche Ltd.
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Universal Biosensors
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. DuPont
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Biosensors International Group, Ltd.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Bio-Rad Laboratories Inc.
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Koninklijke Philips N.V.
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. LifeScan IP Holdings, LLC
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Molecular Devices, LLC.
    • 11.2.10.1. Overview
    • 11.2.10.2. Products & Services
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)